Edgestream Partners L.P. Has 5.19 Million Holdings in Blueprint Medicines Co.
| LYFCX Fund | USD 12.99 0.15 1.17% |
Slightly above 50% of Alphacentric Lifesci's investors are presently thinking to get in. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that some investors are interested at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
Alphacentric |
Edgestream Partners L.P. lifted its holdings in Blueprint Medicines Co. by 443.7 percent during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 56,123 shares of the biotechnology companys stock after acquiring an additional 45,800 shares during the period. Edgestream Partners L.P.s holdings in Blueprint
Read at thelincolnianonline.com
 |
Alphacentric Lifesci Fundamental Analysis
We analyze Alphacentric Lifesci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alphacentric Lifesci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alphacentric Lifesci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Alphacentric Lifesci is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Alphacentric Lifesci Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alphacentric Lifesci mutual fund to make a market-neutral strategy. Peer analysis of Alphacentric Lifesci could also be used in its relative valuation, which is a method of valuing Alphacentric Lifesci by comparing valuation metrics with similar companies.
Peers
Alphacentric Lifesci Related Equities
| PLMPX | Pimco Emerging | 0.28 | ||||
| IGIEX | Ashmore Emerging | 0.12 | ||||
| BXECX | Barings Emerging | 0.13 | ||||
| PIEFX | Pnc Emerging | 1.32 | ||||
| REMVX | Rbc Emerging | 1.56 | ||||
| EGLNX | Eagle Mlp | 1.61 | ||||
| GAGPX | Goldman Sachs | 1.80 | ||||
| JFAMX | Jpmorgan Emerging | 2.09 |
Other Information on Investing in Alphacentric Mutual Fund
Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |